Sign inJoin waitlistJoin the waitlist

Adam Forman

Teaching Faculty · Henry Ford Health

Credentials: · · · · ·

History

Henry Ford Health
Present

Hematology and Medical Oncology
Ascension Providence
2015–2018
Internal Medicine
2011–2014
Wayne State University School of Medicine
2007–2011

Research

The Association of Streptococcus gallolyticus Subspecies pasteurianus Bacteremia with the Detection of Premalignant and Malignant Colonic Lesions
Case report · Case Reports in Gastrointestinal Medicine · 2016 · 16 citations
Multi-arm PEG/silica hydrogel for sustained ocular drug delivery
Journal of Pharmaceutical Sciences · 2014 · 16 citations
Superior Sagittal Sinus Filling Defect in Metastatic Lung Cancer: Tumour Thrombus, Bland Thrombus or Both?
Case report · European Journal of Case Reports in Internal Medicine · 2026 · Last of 7 authors

DO
David Oveisi
1 paper
Douglas Sborov
1 paper
Faith Davies
1 paper
Guarav Chand
1 paper · 1 as a resident
Haseeb Tareen
1 paper · 1 as a resident
JB
Joseph Bubalo
1 paper
Joshua Richter
1 paper
LS
Leonid Shamban
1 paper · 1 as a fellow
Lucio Gordan
1 paper
PS
Prabhat Sinha
1 paper
Prerna Mewawalla
1 paper
Rachel DiLeo
1 paper · 1 as a fellow

Clinical trials

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2039
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2034
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2033
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2021–2028